开云app官网登录入口网页版-官方正版

#镰状细胞#

96篇内容 | 2053人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1615553, encodeId=674416155537c, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=Radiology：镰状细胞性贫血患儿下肢血流动力学的多普勒超声表现, objectType=article, longId=735941, objectId=c2dee35941d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2dee35941d7, replyNumber=0, likeNumber=81, createdTime=2022-08-17, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2dee35941d7, moduleTitle=Radiology：镰状细胞性贫血患儿下肢血流动力学的多普勒超声表现, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c2dee35941d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615552, encodeId=3883161555278, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=Lancet子刊：“镰状细胞贫血”和“恶性疟原虫疟疾”之间的关系——对非洲儿童输血和治疗试验的二次分析, objectType=article, longId=733109, objectId=783fe331097e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=783fe331097e, replyNumber=0, likeNumber=0, createdTime=2022-07-25, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=783fe331097e, moduleTitle=Lancet子刊：“镰状细胞贫血”和“恶性疟原虫疟疾”之间的关系——对非洲儿童输血和治疗试验的二次分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=783fe331097e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615551, encodeId=346916155512c, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=诺华与 Precision合作开发潜在的镰状细胞性贫血基因治疗, objectType=article, longId=730268, objectId=6578e302681b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6578e302681b, replyNumber=0, likeNumber=69, createdTime=2022-06-24, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6578e302681b, moduleTitle=诺华与 Precision合作开发潜在的镰状细胞性贫血基因治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6578e302681b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615550, encodeId=da9a1615550b4, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=NEJM：LentiGlobin基因疗法治疗镰状细胞病, objectType=article, longId=299128, objectId=b4782991281a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4782991281a, replyNumber=0, likeNumber=96, createdTime=2022-02-20, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4782991281a, moduleTitle=NEJM：LentiGlobin基因疗法治疗镰状细胞病, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b4782991281a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615549, encodeId=921f161554927, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=J CEREBR BLOOD F M：镰状细胞性贫血患者静脉脑血流定量与认知的关系, objectType=article, longId=293781, objectId=d2fa293e8143, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2fa293e8143, replyNumber=0, likeNumber=73, createdTime=2022-01-12, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2fa293e8143, moduleTitle=J CEREBR BLOOD F M：镰状细胞性贫血患者静脉脑血流定量与认知的关系, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d2fa293e8143)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615548, encodeId=9346161554896, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=美国FDA扩大镰状细胞病药物Oxbryta的适应症, objectType=article, longId=292406, objectId=ce1b292406d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce1b292406d4, replyNumber=0, likeNumber=0, createdTime=2021-12-22, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce1b292406d4, moduleTitle=美国FDA扩大镰状细胞病药物Oxbryta的适应症, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ce1b292406d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615547, encodeId=ff30161554eb5, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=NEJM：镰状细胞病基因治疗后的急性髓系白血病病例, objectType=article, longId=291889, objectId=250a291889cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=250a291889cd, replyNumber=0, likeNumber=85, createdTime=2021-12-16, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=250a291889cd, moduleTitle=NEJM：镰状细胞病基因治疗后的急性髓系白血病病例, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=250a291889cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615546, encodeId=b359161554670, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=HAEMATOLOGICA：离子载体介导的红细胞渗透肿胀是镰状细胞病治疗的潜在机制, objectType=article, longId=219576, objectId=4e612195e65e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e612195e65e, replyNumber=0, likeNumber=94, createdTime=2021-11-02, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e612195e65e, moduleTitle=HAEMATOLOGICA：离子载体介导的红细胞渗透肿胀是镰状细胞病治疗的潜在机制, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4e612195e65e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615545, encodeId=5e60161554578, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=镰状细胞病肺动脉高压是怎么回事？, objectType=article, longId=219272, objectId=38e82192e202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38e82192e202, replyNumber=0, likeNumber=87, createdTime=2021-10-27, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38e82192e202, moduleTitle=镰状细胞病肺动脉高压是怎么回事？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=38e82192e202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615544, encodeId=70561615544f6, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=Stroke：镰状细胞性贫血患者脑血流动力学与执行功能的关系, objectType=article, longId=210891, objectId=b88d210891e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b88d210891e7, replyNumber=0, likeNumber=62, createdTime=2021-05-08, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b88d210891e7, moduleTitle=Stroke：镰状细胞性贫血患者脑血流动力学与执行功能的关系, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b88d210891e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615543, encodeId=2f271615543b2, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=JAMA：静脉注射泊洛沙姆188对镰状细胞贫血患者疼痛性血管闭塞发作持续时间的影响, objectType=article, longId=210286, objectId=c860210286ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c860210286ac, replyNumber=0, likeNumber=79, createdTime=2021-04-23, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c860210286ac, moduleTitle=JAMA：静脉注射泊洛沙姆188对镰状细胞贫血患者疼痛性血管闭塞发作持续时间的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c860210286ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615542, encodeId=f39716155425a, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=基因疗法LentiGlobin治疗镰状细胞疾病，遭遇滑铁卢, objectType=article, longId=207563, objectId=602220e563ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=602220e563ee, replyNumber=0, likeNumber=94, createdTime=2021-02-26, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=602220e563ee, moduleTitle=基因疗法LentiGlobin治疗镰状细胞疾病，遭遇滑铁卢, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=602220e563ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615541, encodeId=aca916155419c, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=欧洲药品管理局（EMA）授予ARU-1801治疗镰状细胞病的优先药品资格（PRIME）, objectType=article, longId=206793, objectId=2ade206e932f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ade206e932f, replyNumber=0, likeNumber=68, createdTime=2021-02-06, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ade206e932f, moduleTitle=欧洲药品管理局（EMA）授予ARU-1801治疗镰状细胞病的优先药品资格（PRIME）, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2ade206e932f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615540, encodeId=40bc16155406a, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=欧洲药品管理局（EMA）开始审查GBT的镰状细胞疗法Oxbryta, objectType=article, longId=206442, objectId=8d542064424c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d542064424c, replyNumber=0, likeNumber=104, createdTime=2021-02-01, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d542064424c, moduleTitle=欧洲药品管理局（EMA）开始审查GBT的镰状细胞疗法Oxbryta, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8d542064424c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615539, encodeId=bba8161553991, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=N Engl J Med ：首次！CRISPR-Cas9技术可在人体实验中有效治疗镰状细胞贫血和β-地中海贫血, objectType=article, longId=205010, objectId=cced205010d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cced205010d4, replyNumber=0, likeNumber=78, createdTime=2021-01-01, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cced205010d4, moduleTitle=N Engl J Med ：首次！CRISPR-Cas9技术可在人体实验中有效治疗镰状细胞贫血和β-地中海贫血, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=cced205010d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615538, encodeId=777a1615538ec, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=Blood：IL-18介导镰状细胞性心肌病和室性心动过速的发生, objectType=article, longId=204378, objectId=e8dd2043e8be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8dd2043e8be, replyNumber=0, likeNumber=62, createdTime=2020-12-12, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8dd2043e8be, moduleTitle=Blood：IL-18介导镰状细胞性心肌病和室性心动过速的发生, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e8dd2043e8be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615537, encodeId=8960161553ed7, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=Blood：镰状细胞病血管闭塞性危象的预后及生物标志物评估, objectType=article, longId=202548, objectId=e63220254865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e63220254865, replyNumber=0, likeNumber=84, createdTime=2020-10-29, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e63220254865, moduleTitle=Blood：镰状细胞病血管闭塞性危象的预后及生物标志物评估, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e63220254865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615536, encodeId=7db9161553654, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=Vertex和CRISPR Therapeutics的镰状细胞基因疗法已获得PRIME称号, objectType=article, longId=201362, objectId=f56c2013622b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f56c2013622b, replyNumber=0, likeNumber=66, createdTime=2020-09-30, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f56c2013622b, moduleTitle=Vertex和CRISPR Therapeutics的镰状细胞基因疗法已获得PRIME称号, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f56c2013622b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615535, encodeId=f593161553520, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=Blood：血凝素缺乏促进镰状细胞病患者发生急性肾损伤！, objectType=article, longId=199256, objectId=e6831992569f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6831992569f, replyNumber=0, likeNumber=93, createdTime=2020-08-13, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6831992569f, moduleTitle=Blood：血凝素缺乏促进镰状细胞病患者发生急性肾损伤！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e6831992569f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615534, encodeId=950c161553464, content=<a href='/topic/show?id=280196865f7' target=_blank style='color:#2F92EE;'>#镰状细胞#</a>, objectTitle=Brit J Heamatol：镰状细胞病女性羟脲暴露与卵巢储备的关系, objectType=article, longId=198137, objectId=7fa919813e0f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fa919813e0f, replyNumber=0, likeNumber=74, createdTime=2020-07-29, rootId=0, userName=1508842480_96220443, userId=cb4819654385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fa919813e0f, moduleTitle=Brit J Heamatol：镰状细胞病女性羟脲暴露与卵巢储备的关系, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7fa919813e0f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

镰状细胞

2020-05-29

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

Radiology：镰状细胞性贫血患儿下肢血流动力学的多普勒超声表现

2022-08-17

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

Lancet子刊：“镰状细胞贫血”和“恶性疟原虫疟疾”之间的关系——对非洲儿童输血和治疗试验的二次分析

2022-07-25

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

诺华与 Precision合作开发潜在的镰状细胞性贫血基因治疗

2022-06-24

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

NEJM：LentiGlobin基因疗法治疗镰状细胞病

2022-02-20

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

J CEREBR BLOOD F M：镰状细胞性贫血患者静脉脑血流定量与认知的关系

2022-01-12

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

美国FDA扩大镰状细胞病药物Oxbryta的适应症

2021-12-22

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

NEJM：镰状细胞病基因治疗后的急性髓系白血病病例

2021-12-16

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

HAEMATOLOGICA：离子载体介导的红细胞渗透肿胀是镰状细胞病治疗的潜在机制

2021-11-02

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

镰状细胞病肺动脉高压是怎么回事？

2021-10-27

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

Stroke：镰状细胞性贫血患者脑血流动力学与执行功能的关系

2021-05-08

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

JAMA：静脉注射泊洛沙姆188对镰状细胞贫血患者疼痛性血管闭塞发作持续时间的影响

2021-04-23

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

基因疗法LentiGlobin治疗镰状细胞疾病，遭遇滑铁卢

2021-02-26

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

欧洲药品管理局（EMA）授予ARU-1801治疗镰状细胞病的优先药品资格（PRIME）

2021-02-06

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

欧洲药品管理局（EMA）开始审查GBT的镰状细胞疗法Oxbryta

2021-02-01

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

N Engl J Med ：首次！CRISPR-Cas9技术可在人体实验中有效治疗镰状细胞贫血和β-地中海贫血

2021-01-01

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

Blood：IL-18介导镰状细胞性心肌病和室性心动过速的发生

2020-12-12

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

Blood：镰状细胞病血管闭塞性危象的预后及生物标志物评估

2020-10-29

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

Vertex和CRISPR Therapeutics的镰状细胞基因疗法已获得PRIME称号

2020-09-30

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

Blood：血凝素缺乏促进镰状细胞病患者发生急性肾损伤！

2020-08-13

1508842480_96220443 (审核中...)

前往app查看评论内容

#镰状细胞#

Brit J Heamatol：镰状细胞病女性羟脲暴露与卵巢储备的关系

2020-07-29

科室
- - 订阅+
  - 更多科室
工具
服务